LabGenius

LabGenius develops next-generation protein therapeutics using a machine learning-driven evolution engine (EVA).

We use robotic automation, synthetic biology and advanced machine learning to explore protein fitness landscapes and improve multiple drug properties simultaneously.

We are a privately-owned company, backed by top-tier venture capital funds, currently based in London.